![James Lulo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James Lulo
Corporate Officer/Principal presso Rapid Pathogen Screening, Inc.
Posizioni attive di James Lulo
Società | Posizione | Inizio | Fine |
---|---|---|---|
Rapid Pathogen Screening, Inc.
![]() Rapid Pathogen Screening, Inc. Medical/Nursing ServicesHealth Services Rapid Pathogen Screening, Inc. is an emerging biotechnology company strategically focused on designing, developing, and delivering novel point-of-care tests for infectious diseases and inflammatory conditions as well as bio-terrorism and chemical nerve agent blood toxins. The firm’s products include AdenoPlus, InflammaDry, FebriDx. The company was founded by Robert P. Sambursky and Robert W. VanDine in 2004 and is headquartered in Sarasota, FL. | Corporate Officer/Principal | - | - |
Storia della carriera di James Lulo
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Posizioni
Corporate Officer/Principal | 1 |
Settori
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Rapid Pathogen Screening, Inc.
![]() Rapid Pathogen Screening, Inc. Medical/Nursing ServicesHealth Services Rapid Pathogen Screening, Inc. is an emerging biotechnology company strategically focused on designing, developing, and delivering novel point-of-care tests for infectious diseases and inflammatory conditions as well as bio-terrorism and chemical nerve agent blood toxins. The firm’s products include AdenoPlus, InflammaDry, FebriDx. The company was founded by Robert P. Sambursky and Robert W. VanDine in 2004 and is headquartered in Sarasota, FL. | Health Services |
- Borsa valori
- Insiders
- James Lulo
- Esperienza